Immune cell attack on melanoma: new combo shows promise
NCT ID NCT00338377
First seen Nov 01, 2025 · Last updated Jun 15, 2026 · Updated 33 times
Summary
This study tests a treatment that uses a patient's own immune cells (T-cells) to fight advanced melanoma. Some patients also receive a dendritic cell vaccine to boost the immune response. The goal is to see if the combination helps T-cells last longer and shrink tumors better than T-cells alone. The study includes several groups exploring different approaches, including treating brain metastases and using a faster way to grow T-cells.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.